EFI to Report First Quarter 2018 Earnings Results on April 30, 2018
Apr 11, 2018 20:05 pm UTC| Business
FREMONT, Calif., April 11, 2018 -- Electronics For Imaging, Inc. (Nasdaq:EFII), a world leader in customer-focused digital printing innovation, will host its quarterly conference call to discuss first quarter results on...
Apr 11, 2018 20:05 pm UTC| Business
ANDOVER, Mass., April 11, 2018 -- MKS Instruments, Inc. (NASDAQ:MKSI), a global provider of technologies that enable advanced processes and improve productivity, announced today another successful repricing of its...
TTM Technologies, Inc. to Host Analyst and Investor Day on May 24, 2018
Apr 11, 2018 20:05 pm UTC| Business
COSTA MESA, Calif., April 11, 2018 -- TTM Technologies, Inc. (Nasdaq:TTMI), a leading global printed circuit board (“PCB”) manufacturer, today announced that it will host an Analyst and Investor Day on Thursday, May 24,...
ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting
Apr 11, 2018 20:05 pm UTC| Business
MOUNTAIN VIEW, Calif., April 11, 2018 -- ChemoCentryx, Inc., (Nasdaq:CCXI), today announced the presentation of positive safety, efficacy and quality of life results from the Company’s successfully completed Phase II...
Monolithic Power Systems Announces Analyst Day on June 7, 2018
Apr 11, 2018 20:05 pm UTC| Business
San Jose, Calif., April 11, 2018 -- Monolithic Power Systems (MPS) (Nasdaq: MPWR), a leading company in high performance analog solutions, today announced the details of its 2018 Analyst Day. MPS will host the Analyst...
Appian Schedules First Quarter 2018 Financial Results Conference Call
Apr 11, 2018 20:05 pm UTC| Business
RESTON, Va., April 11, 2018 -- Appian (NASDAQ:APPN), a leading low-code and business process management (BPM) platform provider, today announced that it will release financial results for the first quarter 2018 after...
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 11, 2018 20:04 pm UTC| Business
MENLO PARK, Calif., April 11, 2018 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions...